Navigation Links
RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
Date:11/10/2008


First in class drug illustrates early signal of transport of key amyloid

marker from brain

TSX Exchange Symbol: RVX

CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug RVX-208, a first in class ApoA-I/Prebeta-HDL elevating drug, in a post-hoc analysis from the Phase 1a clinical trial found that treatment with RVX-208 resulted in a positive trend on an important marker of cognitive function and Alzheimer's disease, Amyloid-beta40 is an important constituent of amyloid plaques in the brains of Alzheimer's patients. The analysis of the plasma markers for Alzheimer's disease was performed by Dr. D. Larry Sparks, Senior Scientist and Head of the Roberts Laboratory for Neurodegenerative Disease Research at Sun Health Research Institute in Sun City, Arizona.

The Phase 1a trial, a double-blind, dose-escalation, placebo-controlled trial enrolled 24 subjects in three separate dosing cohorts for a period of one week: 6 received placebo, and 6 received 2mg/kg per day, 6 received 3mg/kg per day and 6 received 8 mg/kg per day of RVX-208. Plasma levels of A-beta (A-beta40) were measured on day 1 and 7. A 12-14 percent increase in plasma A-beta40 levels was observed at the highest dose of RVX-208 after 7 days of dosing. Based on the study hypothesis these results trended towards significance versus placebo, even with the minimal number of study subjects.

Emerging evidence from large epidemiology studies such as the Harvard Women's Study, the Honolulu-Asia Aging Study and the Whitehall II study continue to build support for the relationship between poor HDL and ApoA-I levels and decreased cognitive function and Alzheimer's disease. Dr. Sparks's investigation of elective statin use and fractionated cholesterol levels in the ADAPT cohort has identified a significant relationship between elevated HDL levels and better performance on the Mini Mental State
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. International Steering Committee for RVX-208 IVUS Trial Formed
2. Phase 1b/2a Program Commences for RVX-208
3. Industry Leaders Select Resverlogixs RVX-208
4. Dosing for RVX-208 Phase 1a Clinical Study Completed
5. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
6. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
7. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
8. Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Cortheras Relaxin in Acute Heart Failure
9. Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
10. New Study Shares Best Practices in Biopharma Public Relations
11. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)...Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald...TC Bulletin Board: EMDY), a leading,producer and d...powder and,soybean products in China, today announ...g issue of US Food & Drink Executive, a quarte...cutives in the food and beverage industry. , ...
(Date:12/2/2009)... Dec. 2 According to the National ...mericans diagnosed with diabetes already have some...thy, damage to the retina caused by leaky blood ve...h diabetes and is one of the most feared diabetic ...atients who,ve had diabetes for 10 years or more w...
(Date:12/1/2009)... Dec. 1 Reportlinker.com announces... its catalogue: ,, Emerging Clinical Trial Loc...hanging healthcare and regulatory environment ,...Clinical-Trial-Locations---Eastern-Europe-Market-d...-environment.html ,, Over the last decade phar...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...s,Inc. (Nasdaq: RNVS ) announced today that its s...reement with Evotec AG (Frankfurt Stock Exchange:,...ay. The merger is,expected to close by May 5, 2008...g share of Renovis common,stock will be automatica...an American Depositary Share (ADSs) of Evotec, wit...
...roMetic Life Sciences Inc.,("ProMetic") (TSX:PLI) ...olders on Wednesday, May 7, 2008 at 10:30 a.m. (ED... ("Meeting") will be held at the Montreal,Museum o... in Montreal.,Points to be covered are:, - Items...ormation Circular - Corporate Presentations, ...
...unced Thursday,that a majority of the company,s sh...e joining the healthcare workflow technology compa...hirty years of executive experience to,Bio-Optroni... headquarters,in Rochester, NY. The company,s prod...ent and optimization solutions for hospitals, spec...
Other Biology Technology:Renovis Stockholders Approve Acquisition by Evotec 2Prometic provides information for its Annual and Special Meeting of Shareholders 2Former GE, Kodak and SGS Executive Dan Kerpelman to Join Bio-Optronics as President and CEO 2
(Date:12/2/2009)... Duke University Medical Center researchers have ...cancer glioma may be better able to resist radiati... signaling pathway in these cancer stem cells, the...diation in a laboratory experiment. , The work ...er stem cells resist the effects of radiation much...
(Date:12/2/2009)... are reporting the first identification of substan... that changes harmless marine bacteria into killer...s in ACS, Environmental Science & Technology , a ...es note that bleaching already has destroyed up to...ists are searching for ways to slow or stop the da...
(Date:12/2/2009)..., December 2, 2009 Commonly prescribed beta 2 adr...in pregnant women as well as pre-term labor may in... psychiatric pathology, cognitive problems and poo...to a new study published in the December 2009 issu...ogy . , Beta 2 adrenergic agonist drugs as a cla...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 1New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma 12872 2The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 1The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 2The Other Cruciate Ligament 3A Newer Treatments for PCL Tears 50542 3New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 1New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 2New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 3New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 4New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 5New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 6New Report Finds Obesity Epidemic Increases Mississippi Weighs in as Heaviest State 50539 7
...d tool to combat the worsening malaria epidemic in...leagues (from the Institut Pasteur in Paris) have ... on MSP3, a protein present on the surface of the ..., As the researchers report in the international ... the 30 healthy volunteers who received the vaccin...
...gist and flu expert is calling for mandatory vacci...s of protecting patients and hospital staff from w... by other United States researchers show that volu...at each year, nearly 40,000 Americans die from inf... immune systems that cannot readily fend off the d...
...s week in Nature shows for the first time that a m...ock cells that regulate daily activity of Drosophi...of neurons control morning and evening activity an...plunged into darkness for extended periods of time...rning to the evening cells and maintains a 12-hour...
Other Biology News:Johns Hopkins flu expert calls for mandatory vaccination of health care workers 2Johns Hopkins flu expert calls for mandatory vaccination of health care workers 3A resetting signal keeps circadian rhythm on track in Drosophila fruit flies 2
...c Nebulizers are available in two product models -...hese two models is that the 6000AT+ includes a mem...rier aerosol for improved detection limits and red...ection limits for a range of elements by 10-40 tim...
AMV RT HC 600 U from Invitrogen
T4 DNA Ligase; (1 x 103 U/ml) or (5 x 103 U/ml) supplied with 10x ligation buffer that includes ATP from Roche Applied Science
...lyzes the formation of a phosphodiester bonds betw... nicked duplex DNA molecules or between oligonucle...rand at 45 - 65?. Tfi DNA Ligase is stable and act...DNA ligases, Thus, Tfi DNA Ligase is the ideal enz...
Biology Products: